Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Contineum Therapeutics (CTNM) Return on Assets (2024)

Historic Return on Assets for Contineum Therapeutics (CTNM) over the last 2 years, with Q3 2025 value amounting to 0.08%.

  • Contineum Therapeutics' Return on Assets rose 800.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.25% for FY2024, which is N/A changed from last year.
  • Contineum Therapeutics' Return on Assets amounted to 0.08% in Q3 2025, which was up 800.0% from 0.13% recorded in Q2 2025.
  • Contineum Therapeutics' 5-year Return on Assets high stood at 0.15% for Q1 2024, and its period low was 0.2% during Q4 2024.